本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Akoya Biosciences, Inc.

1.24
-0.0200-1.59%
成交量:12.04万
成交额:15.02万
市值:6,184.55万
市盈率:-1.29
高:1.28
开:1.26
低:1.22
收:1.26
数据加载中...
2024/08/05

重要事件披露

Form 8-K - Current report
2024/06/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/04

重要事件披露

Form 8-K - Current report
2024/05/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/13

重要事件披露

Form 8-K - Current report
2024/03/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/05

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/05

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/04

重要事件披露

Form 8-K - Current report
2024/02/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/10

重要事件披露

Form 8-K - Current report
2024/01/08

重要事件披露

Form 8-K - Current report
2024/01/03

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]